Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank67
3Y CAGR+50.7%
5Y CAGR+96.9%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+50.7%/yr
Annual compound
5Y CAGR
+96.9%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
29.6x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$3.67M-27.1%
2024$5.03M-1.0%
2023$5.08M+374.8%
2022$1.07M+129.8%
2021$466000.00+275.8%
2020$124000.00+1140.0%
2019$10000.00-